July 24, 2025 a 03:43 pm
COR: Fundamental Ratio Analysis - Cencora, Inc.
Cencora, Inc. is a prominent player in the pharmaceutical distribution landscape. Known for its robust network and services, the company sources and distributes a wide range of pharmaceutical products, catering to diverse segments of the healthcare industry. Recently rebranded from AmerisourceBergen, it continues its legacy with a focus on innovation and expansion.
Fundamental Rating
The fundamental analysis of Cencora, Inc. reflects a stable performance with an overall 'B' rating. Here's a breakdown of their core financial metrics:
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 5 | |
| Return on Assets | 3 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
Cencora's performance over time indicates stability, with consistent ratings in fundamental metrics:
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-23 | 3 | 5 | 5 | 3 | 1 | 2 | 1 |
| Previous | 0 | 5 | 5 | 3 | 1 | 2 | 1 |
Analyst Price Targets
Recent analyst consensus suggests steady growth for Cencora, Inc., with all metrics aligning:
| High | Low | Median | Consensus |
|---|---|---|---|
| 330 | 330 | 330 | 330 |
Analyst Sentiment
The market sentiment surrounding Cencora, Inc. reflects a generally positive outlook with a consensus of 'Buy':
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 27 | |
| Hold | 15 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Cencora, Inc. represents a stable investment opportunity within the pharmaceutical distribution industry. The company's consistent financial performance, underpinned by strong scores in critical metrics like return on equity and discounted cash flow, illustrates its solid foundation. Analyst sentiment is notably favorable, reinforcing a strong market position. However, potential investors should remain mindful of its debt to equity challenges, ensuring a balanced portfolio approach. As the industry evolves, Cencora's commitment to growth and innovation will be crucial to sustaining its market leadership.